HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.

3rd Edition of International Cancer & Immuno-Oncology Conference

March 15-17, 2027 | Singapore
March 15-17, 2027 | Singapore

Mouth Cancer

Mouth Cancer

Mouth cancer, also known as oral cancer, has been a significant focus in cancer research due to its rising incidence and impact on quality of life. Recent advancements in cancer research have unveiled genetic and molecular markers that aid in early detection and targeted therapies. Studies emphasize the role of lifestyle factors such as tobacco and alcohol use, highlighting the need for preventive measures. Innovative treatments, including immunotherapy and precision medicine, are being explored to improve survival rates and reduce side effects. Additionally, research on the human papillomavirus (HPV) links certain strains to mouth cancer, leading to vaccine development efforts. These breakthroughs underscore the importance of continued investment in research to enhance early diagnosis, treatment options, and ultimately, patient outcomes.

Committee Members
Committee Member - Michael Thompson

Michael Thompson

University of Toronto, Canada
Committee Member - Pietro Salvatori

Pietro Salvatori

Formerly, Humanitas San Pio X Hospital, Italy
Committee Member - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States

Submit your abstract Today

YouTube
WhatsAppWhatsApp